What happens when you stop taking Mounjaro, or another GLP-1 treatment, is that the appetite it was quietening tends to return, and some weight regain is common in the following months. This is biology, not a lack of willpower, and planning the transition with your prescriber gives your progress the best chance of holding.
For many people GLP-1 treatment is a long-term approach rather than a short course. Understanding why regain happens, and what protects against it, matters before you start as much as when you stop.
What happens when you stop taking Mounjaro?
Studies that stopped GLP-1 treatment have generally found people regain a meaningful part of the weight they lost. In the STEP 1 trial extension, participants regained much of their lost weight in the year after semaglutide was withdrawn. The appetite changes fade, hunger returns, and eating drifts back towards former levels unless habits hold it in check. Mounjaro is a GLP-1 based medicine (it also acts on a second gut hormone receptor), so the same pattern applies.
Why regain happens
It is largely biology. Treatment works by turning down hunger signalling; when it stops, that signalling returns and the body's tendency to defend its previous weight reasserts itself. Appetite rises, fullness fades, and eating drifts back towards former levels unless habits hold it in check. Understanding this removes some of the self-blame that regain can bring, and it mirrors why crash diets fail to hold weight off in the long run.
Why do people stop taking Mounjaro or Wegovy?
People stop for different reasons: reaching a weight they are happy with, side effects they would rather not continue with, cost, supply, pregnancy planning, or a clinical decision. None of these is unusual, and the right response depends on the reason. If side effects are the issue, it is often worth reviewing the dose or management first, since many of the common GLP-1 side effects settle rather than force a stop. If you are planning a pregnancy, treatment is stopped, and our guide to GLP-1s and pregnancy planning explains the timing.
What to expect after stopping usually unfolds over weeks to months rather than overnight. Appetite tends to return first, often within a few weeks, and any weight change follows more gradually. Knowing the sequence helps you put maintenance habits in place before hunger returns in full, rather than reacting once it has.
How can you keep weight off after stopping Mounjaro?
The habits that protect progress are largely behavioural and nutritional:
- Keep protein high to preserve the muscle that supports maintenance.
- Maintain resistance and everyday activity.
- Hold on to the eating patterns you built during treatment.
- Prioritise sleep and manage stress, both of which affect appetite.
- Monitor your weight so you can act early if it drifts.
Our guides to weight maintenance after target and protein targets on GLP-1s cover the practical side in more detail. The theme running through all of them is that the habits you keep matter more than any single change, because it is the everyday pattern that either holds weight steady or lets it drift.
Protecting muscle is a particular priority. Weight lost on treatment is not all fat, and muscle helps with day-to-day metabolism and strength. Continuing resistance or strength work, and keeping protein up, gives the body a reason to hold on to muscle rather than shed it, which supports maintenance. Regular movement also helps regulate appetite, so it does double duty.
How long before the appetite effect wears off?
There is no fixed timetable, but appetite tends to return over a few weeks rather than instantly, because the medicine clears from the body gradually. That window is useful: it is the time to make sure your maintenance habits are already running rather than waiting until hunger has fully returned. People who plan for this, and keep the structure they built, tend to fare better than those who treat stopping as a finish line.
Can you stop taking Mounjaro safely?
Any decision to stop, whether by choice or circumstance, is best made with your prescriber rather than abruptly and alone. A plan might include how you taper or stop, what to expect afterwards, how you will support yourself, and when to check back in. For some people continuing treatment is the right long-term choice; for others, a supported transition is appropriate. UK prescribing sits within NICE guidance on obesity management, and the Wegovy product information sets out how the medicine is used and stopped.
Is stopping ever the right choice?
For some people, stopping is the right decision, whether because they have built firm habits, because side effects outweigh the benefit, or because their circumstances have changed. The point is not that GLP-1 treatment must continue indefinitely, but that stopping is a considered step with support around it rather than an abrupt halt. There is no evidence that a slow taper prevents regain, but a planned transition lets you line up nutrition, activity and monitoring so you are not caught out. Our guide to weight-loss injection eligibility covers how treatment is reviewed over time.
The honest picture
Treatment can achieve a great deal, and maintaining the result afterwards takes ongoing effort because the underlying biology does not disappear. Going in with that expectation, and a plan, is the most realistic path to lasting change. If side effects are what is prompting thoughts of stopping, review them with your prescriber first. A supported transition, built around habits you can keep, gives your progress the best chance.
